Melanie Cerullo M.s.

Chief Quality & Regulatory Officer at Recipharm

Melanie Cerullo M.S., CQA has extensive work experience in quality and regulatory roles in the pharmaceutical and biotechnology industry. Melanie currently holds the position of Chief Quality & Regulatory Officer at Recipharm since 2022. Prior to that, they worked at Arranta Bio as the Senior Vice President, Quality & Regulatory from 2021 to 2022, and as the Vice President, Quality & Regulatory from 2020 to 2021.

Melanie also has experience at Wave Life Sciences as the Vice President of CMC and Quality from 2018 to 2020, and as the Head of Quality, Senior Director from 2016 to 2018. Before that, they worked as a Consultant at The BioProcess Institute from 2014 to 2016.

In addition, Melanie has entrepreneurial experience, founding and working as a Principal Consultant at Pharmation, LLC from 2014 to 2016, and as the Founder and Vice President at Touchstone Services, LLC from 2014 to 2016.

Earlier in their career, Melanie worked at Ameridose as the Vice President of Quality from 2010 to 2014, and as the Director of Quality from 2007 to 2010. Melanie also has experience at Amgen, Inc. as a Quality Compliance Specialist, Quality Assurance Supervisor, and Quality Assurance Specialist from 2003 to 2007. Melanie'sfirst role in the industry was as a Quality Control Supervisor at Avecia Biotechnology from 2001 to 2003.

Overall, Melanie Cerullo M.S., CQA brings a wealth of experience in quality and regulatory management to their current role as Chief Quality & Regulatory Officer at Recipharm.

Melanie Cerullo M.S., CQA has a Master's Degree in Quality Assurance and Regulatory Affairs from Temple University, which they obtained from 2005 to 2008. Prior to that, they completed their Bachelor's Degree in Chemistry from Rhode Island College, graduating from 1991 to 1996. Melanie also holds the certification of ASQ-Certified Quality Auditor from ASQ.

Links

Previous companies

Arranta Bio logo
WAVE Life Sciences logo
Amgen logo

Timeline

  • Chief Quality & Regulatory Officer

    August, 2022 - present

View in org chart